Filtered By:
Source: Journal of Stroke and Cerebrovascular Diseases
Condition: Stroke
This page shows you your search results in order of relevance. This is page number 18.
Order by Relevance | Date
Total 6741 results found since Jan 2013.
Comprehensive and Structured 3-month Stroke Follow-up Using the Post-stroke Checklist (The Struct-FU study): A Feasibility and Explorative Study
There is recent evidence supporting that a comprehensive post-stroke treatment program improves outcome. However, the prevalence of stroke-related health problems and the extent of needed interventions have not been well-delineated. The Struct-FU study aims to assess the feasibility of a comprehensive stroke follow-up model and to map stroke-related problems and subsequent multidisciplinary interventions using a modified Post-stroke Checklist (PSC).
Source: Journal of Stroke and Cerebrovascular Diseases - November 27, 2020 Category: Neurology Authors: Teresa Ullberg, Kristina M ånsson, Ida Berhin, Hélène Pessah-Rasmussen Source Type: research
Addressing stroke admissions during COVID-19 pandemic beyond fear and constraining health factors
We read with great interest the recently published paper by Candelaresi et al1 addressing the impact of Covid-19 lockdown on stroke admissions. The manuscript further consolidates the evidence that COVID-19 pandemic has an impact on stroke admissions and the associated quality of care1 –4. Similar to previous studies2,3, fear of exposure to coronavirus was considered to be an important driver to the reduction of stroke admission. Although the reduction of stroke admissions during COVID-19 was proposed to be driven predominantly by decrease of admission of less severe stroke pati ents3,4, there are evidence showing that t...
Source: Journal of Stroke and Cerebrovascular Diseases - February 26, 2021 Category: Neurology Authors: Hip ólito Nzwalo, Nicola Logallo Tags: Letter to the Editor Source Type: research
Chronic Kidney Disease and Risk of Stroke. Resolved Chronic Kidney Disease is A Biomarker Rather Than A Risk Factor for Stroke
Over the last approximate 15 years some have suggested that chronic kidney disease (CKD) is a risk factor for stroke in and of itself. The assertion that CKD is a risk factor for stroke requires more scrutiny. It is possible that CKD is a reflection of severity of conditions such as hypertension and diabetes that are themselves among the most treatable risk factors for stroke or it is possible that the effects of CKD change vascular and related physiological functions and therefor directly contribute to increased risk of stroke and it is also possible that treatments for advance CKD such has hemodialysis could contribute t...
Source: Journal of Stroke and Cerebrovascular Diseases - May 29, 2021 Category: Neurology Authors: Judy Dawod, Bruce M Coull Source Type: research
Association of Initial Potassium Levels with the Type of Stroke in the Emergency Department
Early differentiation of hemorrhagic stroke from ischemic stroke in patients with suspected stroke is essential for subsequent management of the patient. While serum potassium level has been suggested as a marker of acute hemorrhagic conditions,1, 2 little is known about whether the initial serum potassium levels differ based on the type of stroke. If serum potassium levels can help differentiate hemorrhagic stroke from ischemic stroke, this information can be applied in deciding subsequent treatment procedures (e.g., catheter intervention, tissue plasminogen activator administration, and antihypertensive therapy) in setti...
Source: Journal of Stroke and Cerebrovascular Diseases - May 30, 2021 Category: Neurology Authors: Kiyomitsu Fukaguchi, Hiroshi Yamagami, Shoko Soeno, Konan Hara, Toru Shirakawa, Tomohiro Sonoo, Kensuke Nakamura, Tadahiro Goto Source Type: research
Hospital Revisits for Post-Ischemic Stroke Epilepsy after Acute Stroke Interventions
Improvements in acute stroke care, namely the use of intravenous alteplase (IV-tPA) and mechanical thrombectomy (MT), have led to a considerable increase in the proportion of patients who survive a first-time ischemic stroke.1 Despite demonstrated benefits of acute stroke interventions, their impact on long term complications is not yet clear. One such complication is post-ischemic stroke epilepsy (PISE). PISE is estimated to occur in 2 –6% of stroke survivors,2–4 and is associated with poor-quality of life and high mortality in young patients.
Source: Journal of Stroke and Cerebrovascular Diseases - October 21, 2021 Category: Neurology Authors: Lindsey R. Kuohn, Alison L. Herman, Alexandria L. Soto, Stacy C. Brown, Emily J. Gilmore, Lawrence J. Hirsch, Charles C. Matouk, Kevin N. Sheth, Jennifer A. Kim Source Type: research
The Reliability and Validity of Post Stroke Depression Scale in Different Type of Post Stroke Depression Patients
Stroke is the second leading cause of death around the world, and approximately a third of all stroke survivors were have different degree of depression at any time after stroke.1 The repercussions of post-stroke depression (PSD) might cause extend psychological wellbeing, worsen rehabilitation outcomes, even lead to post-stroke mortality.2,3 Therefore, the early detection of PSD is essential to promote the prognosis and avoid unfortunate incidents.
Source: Journal of Stroke and Cerebrovascular Diseases - November 25, 2021 Category: Neurology Authors: Yingying Yue, Rui Liu, Jiu Chen, Yin Cao, Yanfeng Wu, Shining Zhang, Huajie Li, Jijun Zhu, Aiqin Wu, Yonggui Yuan Source Type: research
Depression in Stroke Survivors: Ten-Year Follow-Up. Determinants of the Natural Course of Depressive Symptoms in Stroke Survivors in the Netherlands: The SMART-Medea Study
Stroke is one of the leading causes of mortality and a major cause of disability, due to impairments in functioning, limitations in activities, and restrictions in societal participation.20 Although these consequences vary widely between stroke survivors, the most common consequences are physical impairments, communication disorders, cognitive and emotional problems, and mood disturbances.13,50 Every year 15 million people suffer from stroke,30 in the Netherlands, 40.000 patients have a stroke each year28 Most stroke patients survive the initial illness and the greatest health effect is usually caused by the long-term consequences.
Source: Journal of Stroke and Cerebrovascular Diseases - January 21, 2022 Category: Neurology Authors: A. de Bekker, M.I. Geerlings, I.E. Uitewaal-Poslawsky, J.M. de Man-van Ginkel Source Type: research
Informing Patients with Acute Stroke About their Risk of Dementia: A Survey of UK Healthcare Professionals
People who have a stroke are at an increased risk of developing dementia.1,2 According to the 2021 James Lind Alliance –Stroke Association Priority Setting Partnership, cognitive issues after stroke are a key concern of people who have a stroke.3 Identifying which patients with acute stroke are at risk of dementia could help patients and their carers to plan for the future. However, informing a patient who has jus t had a stroke about their risk of dementia may cause anxiety.
Source: Journal of Stroke and Cerebrovascular Diseases - January 12, 2022 Category: Neurology Authors: Emily L. Ball, Gillian E. Mead, Eugene Y.H. Tang, Dorota Religa, Terence J. Quinn, Susan D. Shenkin Source Type: research
Transition in Incidence Rate of Hospitalised Stroke and Case Fatality Rate in the Hunter Region, Australia, 2001-2019: A Prospective Hospital-Based Study
Introduction: Continuous surveillance of stroke admissions has been conducted in the Hunter region, Australia, over the past two decades. We aimed to describe the trends in incidence rates of hospitalised stroke and case-fatality rates in this region, 2001-2019. Methods: From a hospital-based stroke registry, data for admitted adult stroke patients residing in the Hunter region were collected using ICD-10 codes for ischemic and haemorrhagic stroke. Negative binomial regression and logistic regression analysis were used to analyse trends for age-standardised and age-specific incidence rates of hospitalised stroke and 28-day...
Source: Journal of Stroke and Cerebrovascular Diseases - February 3, 2022 Category: Neurology Authors: Yumi Tomari Kashida, Thomas Lillicrap, Rhonda Walker, Elizabeth Holliday, Md Golam Hasnain, Shinya Tomari, Carlos Garcia-Esperon, Jennifer J. Majersik, Neil J. Spratt, Christopher Levi Source Type: research
Undernutrition at Admission Suppresses Post-Stroke Recovery of Trunk Function
Stroke is one of the most common diseases worldwide, and 50%-85% of stroke patients show post-stroke impairments in motor function.1 Many patients require assistance with activities of daily living (ADL) after stroke due to weakness in arms and legs, which results in reduced walking and holding balance ability.2-4 The decreased post-stroke physical activity and motor function lead to reductions in cardiorespiratory fitness and muscle strength, resulting in further deterioration of ADL in patients with stroke.
Source: Journal of Stroke and Cerebrovascular Diseases - March 20, 2022 Category: Neurology Authors: Keisuke Sato, Tatsuro Inoue, Keisuke Maeda, Akio Shimizu, Junko Ueshima, Yuria Ishida, Takahiro Ogawa, Masaki Suenaga Source Type: research
Another possible determinant for ischemic stroke with nonvalvular atrial fibrillation other than conventional oral anticoagulant treatment: The relationship between whole blood viscosity and stroke ☆
Prevention of ischemic stroke complication of atrial fibrillation (AF) is the crucial target in the disease. Stroke is largely prevented by warfarin and the introduction of new oral anticoagulants. While warfarin reduces stroke by 60 –70%, new oral anticoagulants provide at least equal success to this reduction with appropriate dose and treatment compliance.1,2 Nonetheless, we still encounter thromboembolic ischemic stroke in clinical practice in AF patients taking oral anticoagulants (OAC) and once experienced, stroke can hav e devastating consequences for the patients.
Source: Journal of Stroke and Cerebrovascular Diseases - August 3, 2022 Category: Neurology Authors: Sezen Baglan Uzunget, Kader Eliz Sahin Source Type: research
Effect of metformin on outcome after acute ischemic stroke in patients with type 2 diabetes mellitus
Diabetes mellitus is a well-known risk factor for ischemic stroke and is associated with unfavorable outcome after stroke. Metformin is recommended as first-line treatment in these patients. Pre-stroke metformin use might have neuroprotective properties resulting in reduced stroke severity. However, results of the effects of pre-stroke metformin use on functional outcome are conflicting and has not been previously described in patients with type 2 diabetes mellitus regardless of stroke severity or revascularization treatment.
Source: Journal of Stroke and Cerebrovascular Diseases - August 1, 2022 Category: Neurology Authors: C.J.B.A. Kersten, I.L.H. Knottnerus, E. Heijmans, M. Haalboom, A.A.M. Zandbergen, H.M. den Hertog Source Type: research
Long-term determinants of death after stroke in Ghana: Analysis by stroke types & subtypes
Data on longer-term survival (>5 years) after stroke in sub-Saharan Africa (SSA) are limited in the literature. The prospects of survival after a stroke in SSA is of considerable interest given the steep rise in stroke burden,1,2 the relatively younger age of stroke onset and the under-resourced health care delivery on the continent. Poor short-term survival outcomes are well documented3,4 but there is a need for more longitudinal data to inform policy directives on resource allocation for stroke care.
Source: Journal of Stroke and Cerebrovascular Diseases - August 1, 2022 Category: Neurology Authors: Fred Stephen Sarfo, John Akassi, Emmanuel Ofori, Bruce Ovbiagele Source Type: research
Post-stroke cognitive impairment and the risk of stroke recurrence and death in patients with insulin resistance
Post-stroke cognitive impairment (PSCI) is associated with etiology, severity, and functional outcome of stroke. The risks of recurrent stroke and death in patients with PSCI and insulin resistance (IR) is unknown. The goal of this study was to determine whether global and domain-specific cognitive impairment after stroke in patients with IR was associated with recurrent stroke and death.
Source: Journal of Stroke and Cerebrovascular Diseases - August 27, 2022 Category: Neurology Authors: Kat Schmidt, Melinda C. Power, Adam Ciarleglio, Zurab Nadareishvili, IRIS Study Group Source Type: research
Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention
Early stroke occurrence after ischemic stroke or transient ischemic attack (TIA) remains a significant risk despite advances in secondary prevention. Ischemic stroke is largely a thromboembolic disease, and major efforts to reduce the early risk of recurrent stroke in patients with non-cardioembolic stroke have focused on antiplatelet strategies.1 Improvements in outcome have been associated with novel antiplatelet strategies, but significant residual risk of ischemic stroke and the potential for major bleeding, including intracranial hemorrhage, limit the effectiveness of these options.
Source: Journal of Stroke and Cerebrovascular Diseases - August 27, 2022 Category: Neurology Authors: Mukul Sharma, Carlos A. Molina, Kazunori Toyoda, Daniel Bereczki, Scott E. Kasner, Helmi L. Lutsep, Georgios Tsivgoulis, George Ntaios, Anna Czlonkowska, Ashfaq Shuaib, Pierre Amarenco, Matthias Endres, Hans Christoph Diener, David Gailani, Anja Kahl, Mar Source Type: research
